Figure 2.
NGS analysis of the bone marrow sample at relapse showed deletions of CDKN2A and IKZF1. (B,C) Bone marrow smears before and after dasatinib therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.